Ferrer's Ozenoxacin Shows Superiority in Ph III Impetigo Trial

Ferrer's Ozenoxacin shows superiority in Ph III impetigo trial
Filed under: dual diagnosis recovery

The trial, conducted at 27 centers in the USA, South Africa, Germany, Romania and Ukraine, involved 465 adult and paediatric patients aged two years and older with a clinical diagnosis of bullous or non-bullous impetigo. Ozenoxacin is a novel … In …
{Source}

Pa. may outsource all mental health services for inmates
Filed under: dual diagnosis recovery

"Dual diagnosis treatment for people who also have substance abuse disorders, managing their own illness and perhaps even peer support from other people, that's something that could be organized inside the prison," said Draine, who and has studied …
{Source}